Screening for chronic kidney disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project enrolls adults followed at the Institute for Clinical and Experimental Medicine who are over 50 or adults 18+ with specified cardiovascular or metabolic risk conditions. Participants provide consent for review of medical records and available laboratory data, and kidney function indicators such as eGFR and urine testing will be used where present. The main outcome is the proportion of patients meeting criteria for chronic kidney disease and the share who were not previously diagnosed. Findings will describe prevalence and patterns across risk groups to inform local screening and care priorities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age \> 50 or age \>18 + one of these conditions (history of diabetes, arterial hypertension, ischemic heart disease, stroke, perpheral artery disease, atrial fibrillation, heart failure)
* agree to participate
* followed at the Institute for Clinical and Experimental Medicine

Exclusion Criteria:

* unwilling to participate
* kidney transplant recipient/previous kidney transplantation

Where it's running

• Institute for Clinical and Experimental Medicine
  Prague, Czechia Recruiting

Study contacts

• Study coordinator: Ivan Zahradka, MD
• Email: zahi@ikem.cz
• Phone: +420261364110

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes

  This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07868666

• Impact of TAVR on kidney function in people with aortic valve disease

  This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, RM · NCT07626710

• Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs

  This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.

  Recruiting Odense University Hospital · Odense · NCT07511283

• Oral Semaglutide for CKD and MAFLD in adults with diabetes

  This study tests whether adding oral semaglutide to standard care can slow kidney and liver disease progression in adults with CKD and MAFLD who have type 2 diabetes.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07391267

• Eye-brain-kidney connections in chronic kidney disease

  This study will see if changes in brain network connectivity and retinal blood vessels are linked to cognitive decline and kidney function in adults with chronic kidney disease.

  Recruiting Beijing Friendship Hospital · Beijing, Beijing Municipality · NCT07358572

• Streamlined renal denervation with Spyral for uncontrolled high blood pressure

  This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.

  Recruiting at 20 sites Medtronic Vascular · Melbourne and 20 other locations · NCT07115953

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.